Transfusion and stem cell support in cancer treatment

Hematology/Oncology Clinics of North America

Volumn 10, Issue 2, 1996, Pages 397-429

  Wuest, D L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNITY; ANEMIA; BLEEDING TENDENCY; CANCER; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; ERYTHROCYTE TRANSFUSION; GAMMA IRRADIATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HLA MATCHING; HUMAN; LEUKOCYTE TRANSFUSION; MEDICAL DECISION MAKING; NEUTROPHIL; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; VIRUS TRANSMISSION;

EID: 0030005006     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70345-2     Document Type: Article

References (221)

1. R.I. Abels K.M. Larholt K.D. Krantz Recombinant human erythropoietin (rHuEPO) for the treatment of the anemia of cancer M.J. Murphy Blood Cell Growth Factors: Their Present and Future Use in Hematology Oncology. Proceedings of the Beijing Symposium 1991 Alpha Med Press Dayton, Ohio 121
2. S.P. Adler L.T. Lawrence J. Baggett Prevention of transfusion-associated cytomegalovirus infection in very low-birth-weight infants using frozen blood and donors seronegative for cytomegalovirus Transfusion 24 1984 333
3. M. Akahoshi M. Takanashi M. Masuda A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters Transfusion 32 1992 169
4. K.C. Anderson H.J. Weinstein Transfusion-associated graft-versus-host disease N Engl J Med 323 1990 315
5. K.C. Anderson L.T. Goodnough M. Sayers Variation in blood component irradiation practice: Implications for prevention of transfusion-associated graft-versus-host disease Blood 77 1991 2096
6. J.H. Antin Graft-versus-leukemia: No longer an epiphenomenon Blood 82 1993 2273
7. J.O. Armitage Bone marrow transplantation N Engl J Med 330 1994 827
8. R.H. Aster What makes platelets go? The cloning of thrombopoietin Transfusion 35 1995 1
9. L.J. Ayash A. Elias M. Hunt Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation Br J Haematol 87 1994 153
10. M.T. Aye D.S. Palmer A. Giulivi S. Hashemi Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage Transfusion 35 1995 117
11. B. Barlogie T. Beck Recombinant human erythropoietin and the anemia of multiple myeloma Stem Cells 11 1993 88
12. A. Bell A. Figes D. Oscier Peripheral blood stem cell autografts in the treatment of lymphoid malignancies: Initial experience in three patients Br J Haematol 66 1987 66
13. R.J. Belt C. Leite C.D. Haas R.L. Stephens Incidence of hemorrhagic complications in patients with cancer JAMA 239 1978 2571
14. J.G. Bender L.B. To S. William L.S. Schwartzberg Defining a therapeutic dose of peripheral blood stem cells Journal of Hematotherapy 1 1992 329
15. W. Bensinger T. Price D. Dale The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis Blood 7 1993 1883
16. W.I. Bensinger K. Longin F. Appelbaum Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation Br J Haematol 87 1994 825
17. W.I. Bensinger C.H. Weaver F.R. Appelbaum Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor Blood 85 1995 1655
18. S.S. Bernvil M. Abdulatiff S. Al-Sedairy Fresh frozen plasma contains viable progenitor cells—should we irradiate? Vox Sang 67 1994 405
19. E. Beutler Platelet transfusion: The 20,000/µl trigger Blood 81 1993 1411
20. S. Bhatia J.J. McCullough E.H. Perry Granulocyte transfusions: Efficacy in fungal infections in neutropenic patients following bone marrow transplantation Transfusion 34 1994 226
21. M.R. Bishop J.R. Anderson J.D. Jackson High-dose therapy and peripheral blood progenitor cell transplantation: Effects of recombinant human granulocyte-macro-phage colony-stimulating factor on the autograft Blood 83 1994 610
22. M.A. Blajchman L. Bardossy R.A. Carmen An animal model of allogeneic donor platelet refractoriness: The effect of the time of leukodepletion Blood 79 1992 1371
23. M.A. Blajchman L. Bardossy R.A. Carmen Allogeneic blood-transfusion-induced enhancement of tumor growth: Two animal models showing amelioration by leukodepletion and passive transfer using spleen cells Blood 81 1993 1880
24. N. Blumberg J.M. Heal Transfusion and recipient immune function Arch Pathol Lab Med 113 1989 246
25. N. Blumberg J.M. Heal S.A. Kirkley Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: A cost analysis Am J Hematol 48 1995 108
26. J.O. Bordin L. Bardossy M.A. Blajchman Experimental animal model of refractoriness to donor platelets: The effects of plasma removal and the extent of white cell reduction on allogeneic alloimmunization Transfusion 33 1993 798
27. J.O. Bordin N.M. Heddle M.A. Blajchman Biologic effects of leukocytes present in transfused cellular blood components Blood 84 1994 1703
28. J.O. Bordin L. Bardossy M.A. Blajchman Growth enhancement of established tumors by allogeneic blood transfusions in experimental animals and its amelioration by leukodepletion: The importance of the timing of the leukodepletion Blood 83 1994 344
29. R.A. Bowden M. Sayers N. Flournoy Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation N Engl J Med 314 1986 1006
30. R.A. Bowden M. Sayers C.A. Gleaves Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation: Considerations for blood banks Transfusion 27 1987 478
31. R.A. Bowden J.D. Meyers Transfusion-associated cytomegalovirus infection J.P. Dutcher Modern Transfusion Therapy, vol 2 1990 CRC Press Boca Raton 269
32. R.A. Bowden S.J. Slichter M.H. Sayers Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant Blood 78 1991 246
33. R.A. Bowden Cytomegalovirus: Transmission by blood components and measures of prevention S.J. Nance Blood Safety: Current Challenges 1992 AABB Bethesda 201
34. R.A. Bowden S.J. Slichter M. Sayers A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant Blood 86 1995 3598
35. M.K. Brenner D.R. Rill R.C. Moen Gene-marking to trace origin of relapse after autologous bone marrow transplantation Lancet 341 1993 85
36. T.C. Brittingham H. Chaplin Jr Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets JAMA 165 1957 819
37. D.B. Brubaker Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reactions Transfusion 30 1990 733
38. D.B. Brubaker Transfusion-associated graft-versus-host disease K.C. Anderson P.M. Ness Scientific Basis of Transfusion Medicine: Implications for Clinical Practice 1994 WB Saunders Philadelphia 544
39. W. Brugger K.J. Bross J. Frisch Mobilization of peripheral blood progenitor cells by sequential administration of IL-3 and GM-CSF following chemotherapy with etoposide, ifosfamide, and cisplatin Blood 79 1992 1193
40. W. Brugger K.J. Bross M. Glatt Mobilization of tumor cells and hematopoietic cells into peripheral blood of patients with solid tumors Blood 83 1994 636
41. L.N. Button W.C. DeWolf P.E. Newburger The effects of irradiation on blood components Transfusion 21 1981 419
42. S. Cascinu A. Fedeli E. Del Ferro Recombinant human erythropoietin treatment in cisplatin-associated anemia: A randomized, double-blind trial with placebo J Clin Oncol 12 1994 1058
43. C. Caspar R. Seger J. Burger J. Gmur Effective stimulation of donors for granulocyte transfusion with recombinant methionyl granulocyte colony-stimulating factor Blood 81 1993 2866
44. D.J. Christie R.B. Howe S.S. Lennon S.C. Souro Treatment of refractoriness to platelet transfusion by protein A column therapy Transfusion 33 1993 234
45. F. Colotta F. Re N. Polentarutti Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products Blood 80 1992 2012
46. R.L. Comenzo M.E. Malachowski E.M. Berkman Determining the dose of platelets for transfusion S.R. Kurtz D.B. Brubaker Clinical Decisions in Platelet Therapy 1992 AABB Bethesda 1
47. R.L. Comenzo E.M. Berkman Hematopoietic stem and progenitor cells from blood: Emerging uses for new components for transfusion Transfusion 35 1995 335
48. Conference Consensus Platelet transfusion therapy JAMA 257 1987 1777
49. Consensus Conference: Perioperative red cell transfusion JAMA 260 1988 2700
50. C.F. Craddock J.F. Apperley E.G. Wright Circulating stem cells in mice treated with cyclophosphamide Blood 80 1992 254
51. R.F. Dale R.M. Kipling M.R. Smith Separation of malignant cells during autotransfusion Br J Surg 75 1988 581
52. J. Dausset F.T. Rapaport Transplantation antigen activity of human blood platelets Transplantation 4 1966 182
53. R.J. Davey N.C. McCoy M. Yu The effect of prestorage irradiation on post-transfusion red cell survival Transfusion 32 1992 525
54. Y.C.E. De Fraan-Hentzen J.W. Gratama G.C. Mudde Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products Transfusion 29 1989 757
55. T. Demirer W.I. Bensinger Optimization of peripheral blood stem cell collection Current Opinion in Hematology 2 1995 219
56. M.A. DeRie C.M. van der Plas-van Dalen C.P. Engelfriet The serology of febrile transfusion reactions Vox Sang 49 1985 126
57. T. De Witte A. Schattenber B.A. Van Dijk Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors Transplantation 50 1990 964
58. R.Y. Dodd The risk of transfusion-transmitted infection N Engl J Med 327 1992 419
59. H.A. Doughty M.F. Murphy P. Metcalfe Relative importance of immune and non-immune causes of platelet refractoriness Vox Sang 66 1994 200
60. P. Dreger P. Marquardt T. Haferlach Effective mobilization of peripheral blood progenitor cells with dexa-BEAM and G-CSF-timing of harvesting and composition of the leukapheresis product Br J Cancer 68 1993 950
61. U. Duhrsen J. Villeval J. Boyd Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients Blood 72 1988 2074
62. J.K. Duguid R. Carr J.A. Jenkins Clinical evaluation of the effects of storage time and irradiation on transfused platelets Vox Sang 60 1991 151
63. C.E. Dunbar M. Cottler-Fox J.A. O'Shaughnessy Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation Blood 85 1995 3048
64. J. Dutcher C.A. Schiffer J. Aisner P.H. Wiernik Alloimmunization following platelet transfusion: The absence of a dose response relationship Blood 57 1980 395
65. J.P. Dutcher C.A. Schiffer J. Aisner P.H. Wiernik Long term followup of patients with leukemia receiving platelet transfusions. Identification of a large group of patients who do not become alloimmunized Blood 58 1981 1007
66. J.P. Dutcher C.A. Schiffer J. Aisner Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors Cancer 53 1984 557
67. W.H. Dzik Is the febrile response to transfusion due to donor or recipient cytokine? Transfusion 32 1992 594
68. W.H. Dzik K.S. Jones The effects of gamma irradiation versus white cell reduction on the mixed lymphocyte reaction Transfusion 33 1993 493
69. S. Dzik P. Szuflad S. Eaves HLA antigens on leukocyte fragments and plasma proteins: Prestorage leukoreduction by filtration Vox Sang 66 1994 104
70. L. Einhorn A. Ost Cytomegalovirus infection of human blood cells J Infect Dis 149 1984 207
71. FDA Memorandum: Recommendations regarding license amendments and procedures for gamma irradiation of blood products. July 22, 1993
72. C.R.M.G. Fluit V.A.J.M. Kunst A.M. Drenthe-Schonk Incidence of red cell antibodies after multiple blood transfusion Transfusion 30 1990 532
73. R.C. Friedberg Issues in transfusion therapy in the patient with malignancy Hematol Oncol Clin North Am 8 1994 1223
74. R.C. Friedberg S.F. Donnelly J.C. Boyd Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization Blood 81 1993 3428
75. R.C. Friedberg S.F. Donnelly P.D. Mintz Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients Transfusion 34 1994 215
76. L.A. Gaydos E.J. Freireich N. Mantel The quantitative relation between platelet count and hemorrhage in patients with acute leukemia N Engl J Med 266 1962 905
77. A. Gianni S. Siena M. Bregni Granulocyte-macrophage colony-stimulating factor to harvest circulating haematopoietic stem cells for autotransplantation Lancet 334 1989 580
78. J. Gmur J. Burger U. Schanz Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia Lancet 338 1991 1223
79. J. Goodman G. Hodgson Evidence for stem cells in the peripheral blood of mice Blood 19 1962 702
80. L.T. Goodnough J. Riddell H. Lazarus Prevalence of platelet transfusion reactions before and after implementation of leukocyte-depleted platelet concentrates by filtration Vox Sang 65 1993 103
81. J.C. Gribben A.S. Freedman D. Neuber Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma N Engl J Med 325 1991 1525
82. M.A. Grijzenhout M.I. Aarts-Riemens F.R. deGruijl UVB irradiation of human platelet concentrates does not prevent HLA alloimmunization in recipients Blood 84 1994 3524
83. R. Haas A. Ho U. Bredthauer Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor Exp Hematol 18 1990 94
84. O.J. Hart I.W. Klimberg Z. Wajsman Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder Surg Gynecol Obstet 168 1989 302
85. J.M. Heal J.M. Rowe A. McMican The role of ABO matching in platelet transfusion Eur J Haematol 50 1993 110
86. J.M. Heal N. Blumberg S.A. Kirkley Leukocyte-reduced transfusions of ABO-identical platelets and clinical outcome in autologous bone marrow transplantation for lymphoma Bone Marrow Transplant 14 1994 943
87. N.M. Heddle L. Klama J. Singer The role of the plasma from platelet concentrates in transfusion reactions N Engl J Med 331 1994 625
88. +-selected human peripheral blood progenitor cells Blood 84 1994 2898
89. J. Hester E. Feldman E. Anaissie Collection of granulocyte concentrates from cytokine stimulated normal donors [abstract] J Clin Apheresis 8 1993 40
90. J.K. Higby E. Cohen J.F. Holland L. Sinks The prophylactic treatment of thrombocytopenic leukemic patients with platelets: A double blind study Transfusion 14 1974 440
91. A.D. Ho S. Gluck C. Germond Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer Leukemia 7 1993 1738
92. T.V. Holohan P.I. Terasaki A.B. Deisseroth Suppression of transfusion-related alloimmunization in intensively treated cancer patients Blood 58 1981 122
93. J.E. Howard H.A. Perkins The natural history of alloimmunization to platelets Transfusion 18 1978 496
94. M.A. Hussein T. Long B. Bolwell Response to protein A column in alloimmunized platelet refractory patients Transfusion 34 Suppl 1994 66S
95. D. Inwards A. Kessinger Peripheral blood stem cell transplantation: Historical perspective, current status, and prospects for the future Transfus Med Rev 6 1992 183
96. J. Karp W. Merz J. Dick R. Saral Strategies to prevent or control infections after bone marrow transplants Bone Marrow Transplant 8 1991 1
97. N.A. Kernan N.H. Collins L. Juliano Clonable T lymphocytes in T-cell-depleted bone marrow transplants correlate with development of graft-v-host disease Blood 68 1986 770
98. A. Kessinger H. Armitage J. Landmark Reconstitution of human hematopoietic function with autologous cyropreserved circulating stem cells Exp Hematol 14 1986 192
99. A. Kessinger J. Armitage D. Smith High dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma Blood 74 1989 1260
100. A. Kessinger P. Bierman J. Vose J. Armitage High dose cyclophosphamide, carmustine and etoposide followed by autologous peripheral blood stem cell transplantation for patients with relapsed Hodgkin's disease Blood 77 1991 2322
101. T.S. Kickler H.G. Braine P.M. Ness The predictive value of crossmatching platelet transfusion for alloimmunized patients Transfusion 25 1985 385
102. T.S. Kickler The platelet transfusion refractory state: Transfusion practices and clinical management S.R. Kurtz D.B. Brubaker Clinical Decisions in Platelet Therapy 1992 AABB Bethesda 87
103. S. Kiesel Pezzutto M. Korbling Autologous peripheral blood stem cell transplantation: Analysis of autografted cells and lymphocyte recovery Transplant Proc 21 1989 3084
104. S. Klaesson O. Ringden P. Ljungman Reduced blood transfusions requirements after allogeneic bone marrow transplantation: Results of a randomized double-blind study with high-dose erythropoietin Bone Marrow Transplant 13 1994 397
105. I. Klimberg R. Sirois Z. Wajsman Intraoperative autotransfusion in urologic oncology Arch Surg 121 1986 1326
106. H. Klingemann J. Shepherd C. Eaves A. Eaves The role of erythropoietin and other growth factors in transfusion medicine Transfus Med Rev 5 1991 33
107. M. Korbling B. Dorken A. Ho Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma Blood 67 1986 529
108. M. Korbling D. Przepiorka Y.O. Huh Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts Blood 85 1995 1659
109. E.J. Lee C.A. Schiffer Serial measurement of lymphocytotoxic antibody and response to non-matched platelet transfusions in alloimmunized patients Blood 70 1987 1727
110. S.F. Leitman Use of blood cell irradiation in the prevention of posttransfusion graft-vs-host disease Transfusion Science 10 1989 219
111. G. Lieschke A. Burgess Granulocyte colony-stimulating factor and granulocyte-macro-phage colony-stimulating factor. Part I N Engl J Med 327 1992 28
112. F. Locatelli M. Zecca P. Pedrazzoli Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: Effect on erythroid repopulation in autologous versus allogeneic transplants Bone Marrow Transplant 13 1994 403
113. J. Lopez M.J. Fernandez-Villalta F. Gomez-Reino Absence of graft-versus-leukemia effect of standard chemotherapy in patients with acute myeloblastic leukemia Transfusion 30 1990 191
114. P. Lowry I. Tabbara Peripheral hematopoietic stem cell transplantation: Current concepts Exp Hematol 20 1992 937
115. N.L. Luban A.E. Williams M.G. McDonald Low incidence of cytomegalovirus infection in neonates transfused with washed red blood cells Am J Dis Child 141 1987 416
116. N.L.C. Luban R.A. Sacher Transfusion-transmitted cytomegalovirus and Epstein-Barr diseases E.C. Rossi T.L. Simon G.W. Moss Principle of Transfusion Medicine 1991 Williams & Wilkins Baltimore 597
117. N.L. Luban Cytomegalovirus K.C. Anderson P.M. Ness Scientific Basis of Transfusion Medicine: Implications for Clinical Practice 1994 WB Saunders Philadelphia 637
118. H. Ludwig E. Fritz H. Kotzman Erythropoietin treatment of anemia associated with multiple myeloma N Engl J Med 322 1990 1693
119. S. Mackinnon E.B. Papadopoulos M.H. Carabasi Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-vs-leukemia responses from graft-vs-host disease Blood 86 1995 1261
120. M.M. Mangano L.A. Chambers M.S. Kruskall Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions Am J Clin Pathol 95 1991 733
121. D. McCarthy J. Goldman Transfusion of circulating stem cells Crit Rev Clin Lab Sci 20 1984 1
122. J. McCullough A new generation of blood components Transfusion 32 1992 299
123. J.G. McFarland A.J. Anderson S.J. Slichter Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates Br J Haematol 73 1989 380
124. J.E. Menitove L.R. Kagen R.H. Aster Alloimmunization is decreased in patients receiving UV-B irradiated platelet concentrates and leukocyte-depleted red cells Blood 76 Suppl 1990 1607
125. J.D. Meyers N. Flournoy E.D. Thomas Risk factors for cytomegalovirus infection after human marrow transplantation J Infect Dis 153 1986 478
126. J.D. Meyers Prevention and treatment of cytomegalovirus infection after marrow transplantation Bone Marrow Transplant 3 1988 95
127. C.B. Miller L.C. Platanias S.R. Mills Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia J Natl Cancer Inst 84 1992 98
128. J.P. Miller P.D. Mintz The use of leukocyte-reduced blood components Hematol Oncol Clin North Am 9 1995 69
129. W. Miller P. Flynn J. McCullough Cytomegalovirus infection after bone marrow transplantation: An association with acute graft-v-host disease Blood 67 1986 1162
130. W.J. Miller J. McCullough H.H. Balfour Prevention of cytomegalovirus infection following bone marrow transplantation: A randomized trial of blood product screening Bone Marrow Transplant 7 1991 227
131. J. Mishler J. Hester D. Huestis Dosage and scheduling regimens for erythrocyte sedimenting macromolecules J Clin Apheresis 1 1983 130
132. A.J. Mitus J.H. Antin C.J. Rutherford Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs Blood 83 1994 1952
133. G. Moroff G. Garratty J.M. Heal Selection of platelets for refractory patients by HLA matching and prospective crossmatching Transfusion 32 1992 633
134. C. Moskowitz P. Stiff M. Gordon The influence of extensive prior chemotherapy on the mobilization of peripheral blood progenitor cells (PBPC) using stem cell factor (rhSCF) and filgrastim (rmetHuG-CSF) and on hematologic recovery post cyclophosphamide, BCNU, and VP-16 (CBV) in patients with relapsed non-Hodgkin's lymphoma (NHL): An interim analysis Blood 84 Suppl 1994 107a
135. T. Moss A. Ross The risk of tumor cell contamination in peripheral blood stem cell collections Journal of Hematotherapy 1 1992 225
136. M.F. Murphy P. Metcalfe J. Ord Disappearance of HLA and platelet-specific antibodies in acute leukemia patients alloimmunized by multiple transfusions Br J Haematol 67 1987 255
137. M.F. Murphy P.C. Grint A.E. Hardiman Use of leukocyte-poor blood components to prevent primary cytomegalovirus (CMV) infection in patients with acute leukemia Br J Haematol 70 1988 253
138. S. Murphy S. Litwin L.M. Herring Indications for platelet transfusion in children with acute leukemia Am J Hematol 12 1982 347
139. L. Muylle M. Joos E. Wouters Increased tumor necrosis factor α (TNFα), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: Relationship between TNF α and IL-6 levels and febrile transfusion reactions Transfusion 33 1993 195
140. A. Nademanee I. Sniecinski G.M. Schmidt High-dose therapy followed by autologous peripheral-blood stem cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells J Clin Oncol 12 1994 2176
141. National Blood Resource Education Program, National Heart, Lung and Blood Institute The use of autologous blood. The National Blood Resource Education Program expert panel JAMA 263 1990 414
142. R.S. Negrin C.R. Kusnierz-Glaz B.J. Still Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma Blood 85 1995 3334
143. P.M. Ness R.S. Shirey S.K. Thoman The differentiation of delayed serologic and delayed hemolytic transfusion reactions: Incidence, long-term serologic findings, and clinical significance Transfusion 30 1990 688
144. F. Norol N. Parquet M. Kuentz Absence of graft-versus-leukaemia (GVL) effect by leucocytes transfused: A prospective randomized trial in acute myeloid leukaemia (AML) patients Br J Haematol 78 1991 591
145. W. Nothdurft C. Bruch T. Fliedner Studies on the regeneration of the CFU-C population in blood and bone marrow of lethally irradiated dogs after autologous transfusion of cryopreserved mononuclear blood cells Scand J Haematol 19 1977 470
146. V.M.J. Novotny R. van Doorn M.D. Witvliet Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: A prospective study Blood 85 1995 1736
147. K. Oksanen E. Elonen Impact of leucocyte-depleted blood components on the haematological recovery and prognosis of patients with acute myeloid leukaemia Br J Haematol 84 1993 639
148. W. Oster F. Herrmann H. Gamm Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration J Clin Oncol 8 1990 956
149. E.B. Papadopoulos M. Ladanyi D. Emanuel Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation N Engl J Med 330 1994 1185
150. R. Pecego R. Hill F.R. Appelbaum Interstitial pneumonitis following autologous bone marrow transplantation Transplantation 42 1986 515
151. M.M. Pelszynski G. Moroff N.L. Luban Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: Implications for preventing transfusion-associated graft-versus-host disease Blood 83 1994 1683
152. H.A. Perkins R. Payne J. Gerguson Nonhemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes Vox Sang 11 1966 578
153. R. Pettengell Morgenstern GR, Woll PJ, et al: Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis Blood 82 1993 3770
154. R. Pettengell T. Luft R. Henschler Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells Blood 84 1994 3653
155. L.D. Petz L. Calhoun P. Yam Transfusion-associated graft-versus-host disease in immunocompetent patients: Report of a fatal case associated with transfusion of blood from second-degree relative, and a survey of predisposing factors Transfusion 33 1993 742
156. J.K. Preiksaitis Indications for the use of cytomegalovirus-seronegative blood products Transfus Med Rev 5 1991 1
157. A.M. Ramirez D.G. Woodfield R. Scott High potassium levels in stored irradiated blood Transfusion 27 1987 444
158. E.J. Read C. Kodis C.S. Carter Viability of platelets following storage in the irradiated state Transfusion 28 1988 446
159. P. Rebulla M. Pappalettera T. Barbui Duration of first remission in leukaemic recipients of leucocyte-poor blood components Br J Haematol 75 1990 441
160. J. Reiffers P. Bernard B. David Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia Exp Hematol 14 1986 312
161. A. Rice J. Reiffers Mobilized blood stem cells: Immunophenotyping and functional characteristics Journal of Hematotherapy 1 1992 19
162. P.B. Rintels R.M. Kenney J.P. Crowley Therapeutic support of the patient with thrombocytopenia Hematol Oncol Clin North Am 8 1994 1131
163. C. Rivet A. Baxter G. Rock Potassium levels in irradiated blood Transfusion 29 1989 185
164. G. Rock G.A. Adams R.S. Labow The effects of irradiation on platelet function Transfusion 28 1988 451
165. A.M. Ross B.W. Cooper H.M. Lazarus Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques Blood 82 1993 2604
166. A. Rubinstein J. Radl H. Cottier Unusual combined immunodeficiency syndrome exhibiting kappa-IgD paraproteinemia, residual gut immunity and graft-versus-host reaction after plasma infusion Acta Paediatr Scand 62 1973 365
167. P. Rubinstein R.E. Rosenfield J.W. Adamson C.E. Stevens Stored placental blood for unrelated bone marrow reconstitution Blood 81 1993 1679
168. N. Russel S. Pacey Economic evaluation of peripheral blood stem cell transplantation for lymphoma Lancet 340 1992 1290
169. R.A. Sacher N.L.C. Luban Transfusion-associated graft-versus-host disease E.C. Rossi T.L. Simon G.S. Moss Principles of Transfusion Medicine 1991 Williams & Wilkins Baltimore 649
170. M.H. Sayers K.C. Anderson L.T. Goodnough Reducing the risk for transfusion-transmitted cytomegalovirus infection Ann Intern Med 116 1992 55
171. K. Sazama Reports of 355 transfusion-associated deaths: 1976 through 1985 Transfusion 30 1990 583
172. C.A. Schiffer Prevention of alloimmunization against platelets Blood 77 1991 1 4
173. N. Schmitz P. Drefer M. Suttorp Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood 85 1995 1666
174. L. Schwartzberg R. Birch B. Hazelton Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor Journal of Hematotherapy 1 1992 317
175. + cells from patients with stage IV breast cancer Blood 84 1994 3567
176. W. Sheridan C. Begley C. Juttner Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy Lancet 339 1992 640
177. R.S. Shirey P.M. Ness Alloimmunization to blood group antigens K.C. Anderson P.M. Ness Scientific Basis of Transfusion Medicine. Implications for Clinical Practice 1994 WB Saunders Philadelphia 507
178. E.J. Shpall R.B. Jones S.I. Bearman Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment J Clin Oncol 12 1994 28
179. S. Siena M. Bregni B. Brando Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients Blood 77 1991 400
180. K. Sintnicolaas M. van Marwijk Kooij H.C. van Prooijen Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: A random prospective study Blood 85 1995 824
181. S. Slichter L.A. Harker Thrombocytopenia: Mechanisms and management of defects in platelet production Clin Haematol 7 1978 523
182. S.J. Slichter Mechanisms and management of platelet refractoriness S.T. Nance Transfusion Medicine in the 1990's 1990 AABB Arlington 95
183. S.J. Slichter Principles of transfusion support before and after bone marrow transplantation E.C. Rossi T.L. Simon G.S. Moss Principles of Transfusion Medicine 1991 Williams & Wilkins Baltimore 273
184. S.J. Slichter H.J. Deeg M.S. Kennedy Prevention of platelet alloimmunization in dogs with systemic cyclosporine and by UV-irradiation or cyclosporine-loading of donor platelets Blood 69 1987 414
185. D.M. Smith Immunosuppressive effects of blood transfusion Clin Lab Med 12 1992 723
186. I. Sniecinski D.J. Christie R.B. Howe Utilization of protein A immunoadsorption therapy for treatment of refractoriness to platelet transfusion [abstract] J Clin Apheresis 10 1995 51
187. M. Socinski S. Cannistra A. Elias Granulocyte-macrophage colony stimulating factor expands the circulating haematopoietic progenitor cell compartment in man Lancet 331 1988 1194
188. J. Solomon T. Bofenkamp J.L. Fahey Platelet prophylaxis in acute nonlymphoblastic leukemia Lancet 311 1978 267
189. R.T. Spielberger M.J. Falleroni A.M. Coene Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration of disseminated infection with Fusarium in a granulocytopenic patient Clin Infect Dis 16 1993 528
190. G. Stack E.L. Snyder Cytokine generation in stored platelet concentrates Transfusion 34 1994 20
191. J.L. Steegman J. Lopez M.J. Otero Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: Results of a prospective controlled randomized trial Bone Marrow Transplant 10 1992 541
192. R. Storb R.L. Prentice E.D. Thomas Marrow transplantation for treatment of aplastic anemia: An analysis of factors associated with graft rejection N Engl J Med 296 1977 61
193. R. Storb T. Graham R.B. Epstein Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation Blood 50 1977 537
194. R. Strauss J. Hester W. Vogler A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors Transfusion 26 1986 258
195. R. Strauss P. Rohret M. Randels D. Winegarden Granulocyte collection J Clin Apheresis 6 1991 241
196. R.G. Strauss Therapeutic granulocyte transfusions in 1993 Blood 81 1993 1675
197. R.G. Strauss Granulocyte transfusion therapy Hematol Oncol Clin North Am 8 1994 1159
198. B. Swerdlow S. Deresinski Development of aspergillus sinusitis in a patient receiving amphotericin B Am J Med 76 1984 162
199. C. Tarella D. Ferrero M. Bregni Peripheral blood expansion of early progenitor cells after high dose cyclophosphamide and rhGM-CSF Eur J Cancer 27 1991 22
200. B.J. Taylor R.F. Jacobs R.L. Baker Frozen deglycerolyzed blood prevents transfusion-acquired cytomegalovirus infections in neonates Pediatr Infect Dis 5 1986 188
201. + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor Blood 84 1994 2795
202. L. To D. Haylock R. Kimber C. Juttner High levels of circulating haemaopoietic stem cells in very early remission from acute non-lymphoblastic leukameia and their collection and cryopreservation Br J Haematol 58 1984 399
203. L. To K. Sheppard D. Haylock Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood Exp Hematol 18 1990 442
204. L. To M. Roberts D. Haylock Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants Bone Marrow Transplant 9 1992 277
205. + cells Blood 84 1994 2930
206. J. Tucker M.F. Murphy W. Gregory Apparent removal of graft-versus-leukaemia effect by the use of leucocyte-poor blood components in patients with acute myeloblastic leukaemia Br J Haematol 69 1988 118
207. L.W. Turtinen R. Saltzman M.C. Jordan A.T. Haase Interactions of human cytomegalovirus with leukocytes in vivo: Analysis by in situ hybridization Microb Pathog 3 1987 287
208. N.H. Valerius K.S. Johansen O.S. Nielsen Effect of in vitro x-irradiation on lymphocyte and granulocyte function Scand J Haematol 27 1981 9
209. D.W. Van Bekkum Transfusion or transplantation? Isr J Med Sci 1 1965 879
210. A.M. Vannucchi A. Bosi A. Grossi Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients Leukemia 6 1992 25
211. L.F. Verdonck Y.C.E. de Graan-Hentzen A.W. Dekker Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation Bone Marrow Transplant 2 1987 73
212. A.J. Vora C.H. Toh J. Peel M. Greaves Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: Risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration Br J Haematol 86 1994 180
213. F.F. Wagner W.A. Flegel Transfusion-associated graft-versus-host disease: Risk due to homozygous HLA haplotypes Transfusion 35 1995 284
214. J.E. Wagner N.A. Kernan M. Steinbuch Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease Lancet 346 1995 214
215. + cells Blood 84 1994 1408
216. B. Wenz Microaggregate blood filtration and the febrile transfusion reaction: A comparative study Transfusion 23 1983 95
217. J.U. Wieding K. Vehmeyer J. Dittman Contamination of fresh-frozen plasma with viable white cells and proliferable stem cells Transfusion 34 1994 185
218. L.M. Williamson J.Z. Wimperis P. Williamson Bedside filtration of blood products in the prevention of HLA alloimmunization—A prospective randomized trial Blood 83 1994 3028
219. J.R. Wingard D.Y. Chen W.H. Burns Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation Blood 71 1988 1432
220. E. Winton R. Vogler J. Mishler Dosage and scheduling regimens for glucocorticoids J Clin Apheresis 1 1983 144
221. X.Q. Yan C. Hartley P. McElroy Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice Blood 85 1995 2303